BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9354592)

  • 1. Prostanoid receptor with a novel pharmacological profile in human erythroleukemia cells.
    Feoktistov I; Breyer RM; Biaggioni I
    Biochem Pharmacol; 1997 Oct; 54(8):917-26. PubMed ID: 9354592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Positive modulation of intracellular Ca2+ levels by adenosine A2b receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells.
    Feoktistov I; Murray JJ; Biaggioni I
    Mol Pharmacol; 1994 Jun; 45(6):1160-7. PubMed ID: 8022409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of prostaglandin and thromboxane receptors expressed on a megakaryoblastic leukemia cell line, MEG-01s.
    Watanabe T; Yatomi Y; Sunaga S; Miki I; Ishii A; Nakao A; Higashihara M; Seyama Y; Ogura M; Saito H
    Blood; 1991 Nov; 78(9):2328-36. PubMed ID: 1718495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor-mediated increases in cytosolic Ca2+ in the human erythroleukaemia cell line involve pertussis toxin-sensitive and -insensitive pathways.
    Schwaner I; Seifert R; Schultz G
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):301-7. PubMed ID: 1310589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prostacyclin analogues, cicaprost and iloprost, increase cytosolic Ca2+ concentration in the human erythroleukemia cell line, HEL, via pertussis toxin-insensitive G-proteins.
    Schwaner I; Seifert R; Schultz G
    Eicosanoids; 1992; 5 Suppl():S10-2. PubMed ID: 1280455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of Gi and Gs proteins by E- and I-type prostaglandins in membranes from the human erythroleukaemia cell line, HEL.
    Schwaner I; Offermanns S; Spicher K; Seifert R; Schultz G
    Biochim Biophys Acta; 1995 Feb; 1265(1):8-14. PubMed ID: 7532011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of thrombin- or ATP-induced mobilization of intracellular Ca2+ by prostacyclin receptor in mouse mastocytoma cells.
    Negishi M; Hashimoto H; Ichikawa A
    Biochem Biophys Res Commun; 1991 Apr; 176(1):102-7. PubMed ID: 1708239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein kinase C plays a key role in the cross-talk between intracellular signalings via prostanoid receptors in a megakaryoblastic cell line, MEG-01s.
    Watanabe T; Sunaga S; Togo M; Satoh H; Higashihara M; Hashimoto Y; Kurokawa K
    Biochim Biophys Acta; 1996 Nov; 1304(2):161-9. PubMed ID: 8954139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive and negative regulation of cell proliferation through prostaglandin receptors in NIH-3T3 cells.
    Watanabe T; Satoh H; Togoh M; Taniguchi S; Hashimoto Y; Kurokawa K
    J Cell Physiol; 1996 Nov; 169(2):401-9. PubMed ID: 8908208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct relationship between intracellular calcium mobilization and phospholipase D activation in prostaglandin E-stimulated human erythroleukemia cells.
    Wu H; James-Kracke MR; Halenda SP
    Biochemistry; 1992 Apr; 31(13):3370-7. PubMed ID: 1313295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual regulation of cyclic AMP formation by thrombin in HEL cells, a leukaemic cell line with megakaryocytic properties.
    Brass LF; Woolkalis MJ
    Biochem J; 1992 Jan; 281 ( Pt 1)(Pt 1):73-80. PubMed ID: 1310010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostacyclin receptor-independent inhibition of phospholipase C activity by non-prostanoid prostacyclin mimetics.
    Chow KB; Wong YH; Wise H
    Br J Pharmacol; 2001 Dec; 134(7):1375-84. PubMed ID: 11724742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent down-regulation of IP prostanoid receptors and the alpha-subunit of the stimulatory guanine-nucleotide-binding protein (Gs) during prolonged exposure of neuroblastoma x glioma cells to prostanoid agonists. Quantification and functional implications.
    Adie EJ; Mullaney I; McKenzie FR; Milligan G
    Biochem J; 1992 Jul; 285 ( Pt 2)(Pt 2):529-36. PubMed ID: 1379045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology of functional endogenous IP prostanoid receptors in NCB-20 cells: comparison with binding data from human platelets.
    Crider JY; Xu SX; Sharif NA
    Prostaglandins Leukot Essent Fatty Acids; 2001; 65(5-6):253-8. PubMed ID: 11993717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist.
    Whittle BJ; Silverstein AM; Mottola DM; Clapp LH
    Biochem Pharmacol; 2012 Jul; 84(1):68-75. PubMed ID: 22480736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activation of a chimeric Gi1/Gs G protein alpha subunit by the human IP prostanoid receptor: analysis using agonist stimulation of high affinity GTPase activity and [35S]guanosine-5'-O-(3-thio)triphosphate binding.
    Fong CW; Bahia DS; Rees S; Milligan G
    Mol Pharmacol; 1998 Aug; 54(2):249-57. PubMed ID: 9687565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 2-adrenergic receptor stimulation mobilizes intracellular Ca2+ in human erythroleukemia cells.
    Michel MC; Brass LF; Williams A; Bokoch GM; LaMorte VJ; Motulsky HJ
    J Biol Chem; 1989 Mar; 264(9):4986-91. PubMed ID: 2564396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of prostanoid receptors on rat neutrophils.
    Wise H; Jones RL
    Br J Pharmacol; 1994 Oct; 113(2):581-7. PubMed ID: 7834211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of cyclic adenosine monophosphate production by thrombin in the human erythroleukemia cell line, HEL.
    Turner JT; Camden JM; Kansra S; Shelton-James D; Wu H; Halenda SP
    J Pharmacol Exp Ther; 1992 Nov; 263(2):708-16. PubMed ID: 1331412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.